Brand and Other Names:Demadex
- Classes: Diuretics, Loop
Dosing & Uses
Dosage Forms & Strengths
Congestive Heart Failure
10-20 mg PO/IV once daily initially; doubled until desired diuretic effect is achieved; individual dose not to exceed 200 mg
Chronic Renal Failure
20 mg PO/IV once daily initially; doubled until desired diuretic effect is achieved; individual dose not to exceed 200 mg
5-10 mg PO/IV once daily initially with aldosterone antagonist or potassium-sparing diuretic; individual dose not to exceed 40 mg
2.5-5 mg/day PO initially; increased to 10 mg/day PO in 4-6 weeks PRN
Use for fluid retention refractory to thiazides or with impaired renal function
- Normal saline may be used for volume replacement
- Dopamine or norepinephrine may be used to treat hypotension
- If dysrhythmia due to decreased potassium or magnesium is suspected, replace aggressively
- Discontinue treatment if no symptoms are apparent after 6 hours
Safety and efficacy not established
Serious - Use Alternative
Significant - Monitor Closely
Excessive urination (7%)
Electrolyte imbalance (2-4%)
Low back pain
Ototoxicity (tinnitus and hearing loss, usually reversible; avoid doses >200 mg)
Serious skin reactions (ie, Stevens-Johnson syndrome, toxic epidermal necrolysis)
Documented hypersensitivity to torsemide or sulfonamides
Use with caution in diabetes mellitus, fluid or electrolyte imbalance (hypokalemia, hyponatremia), hyperglycemia, hyperlipidemia, hyperuricemia or gout, severe liver disease with cirrhosis and ascites
Risk of ototoxicity (occurring after rapid IV injection)
Use with caution in cirrhosis; avoid changes in fluid and electrolyte balance and acid-base status, which may lead to hepatic encephalopathy
Monitor fluid status and renal function to prevent azotemia, oliguria, and reversible increases in blood urea nitrogen (BUN) and creatinine
Pregnancy & Lactation
Pregnancy category: B
Lactation: Unknown whether drug is excreted into breast milk; use with caution
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
Sulfonylurea diuretic; loop diuretic acting at Na-K-2Cl reabsorptive pump at ascending loop of Henle; interferes with chloride-binding cotransport system, causing increased excretion of water, sodium, chlorine, magnesium, and calcium
Onset: PO, 1 hr
Duration: PO, 6-8 hr; IV, 6 hr
Peak plasma time: PO, 1 hr
Peak effect: Diuresis, 1-2 hr; antihypertensive effect, 4-6 wk
Protein bound: 99%
Vd: 12-15 L (doubled in cirrhosis)
Metabolized in liver by CYP450 system
Metabolites: M1 (active), M3 (active), M5 (inactive)
Half-life: 3.5 hr
Dialyzable: Hemodialysis, no
Renal clearance: 0.38-0.78 L/hr
Excretion: Urine (20%)
Administer either as slow injection over 2 minutes or as continuous infusion
If given through IV line, flushing with NS before and afterward is recommended
Store at controlled room temperature
Protect from freezing
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Select a box to add or remove a plan.
Select a class to view formulary status for similar drugs